Skip to main content
Targeting LRRK2 mutations in Parkinson's disease. Future medicinal chemistry Lesniak, R. K., Nichols, R. J., Smith, M., Montine, T. J. 2022

View details for DOI 10.4155/fmc-2022-0102

View details for PubMedID 35730403